I-GEP Trademark

Trademark Overview

On Wednesday, April 14, 2021, a trademark application was filed for I-GEP with the United States Patent and Trademark Office. The USPTO has given the I-GEP trademark a serial number of 90644563. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, October 21, 2024. This trademark is owned by Castle Biosciences Incorporated. The I-GEP trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of integrating the pathology of a tumor, mycotic activity and thickness with a gene expression test using artificial intelligence
i-gep

General Information

Serial Number90644563
Word MarkI-GEP
Filing DateWednesday, April 14, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, October 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2022

Trademark Statements

Pseudo MarkI GENE EXPRESSION PROFILE; I GENE EXPRESSION PROFILING
Goods and ServicesMedical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of integrating the pathology of a tumor, mycotic activity and thickness with a gene expression test using artificial intelligence

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 21, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCastle Biosciences Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77546
Party NameCastle Biosciences Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77546

Trademark Events

Event DateEvent Description
Saturday, April 17, 2021NEW APPLICATION ENTERED
Wednesday, July 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 29, 2021ASSIGNED TO EXAMINER
Wednesday, December 1, 2021NON-FINAL ACTION WRITTEN
Wednesday, December 1, 2021NON-FINAL ACTION E-MAILED
Wednesday, December 1, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 25, 2022SOU EXTENSION 1 FILED
Tuesday, October 25, 2022SOU EXTENSION 1 GRANTED
Thursday, October 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 10, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 10, 2023SOU EXTENSION 2 FILED
Monday, April 10, 2023SOU EXTENSION 2 GRANTED
Wednesday, April 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 2, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 2, 2023SOU EXTENSION 3 FILED
Monday, October 2, 2023SOU EXTENSION 3 GRANTED
Wednesday, October 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 23, 2024SOU EXTENSION 4 FILED
Tuesday, April 23, 2024SOU EXTENSION 4 GRANTED
Wednesday, April 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2024SOU EXTENSION 5 FILED
Monday, October 21, 2024SOU EXTENSION 5 GRANTED

Related Keywords

purposes medical treatment diagnostic testing test expression intelligence gene artificial